Mitochondrial DNA copy number variation and pancreatic cancer risk in the prospective EPIC cohort
Background: Mitochondrial DNA (mtDNA) copy number in peripheral blood has been found to be associated with risk of developing several cancers. However, data on pancreatic ductal adenocarcinoma (PDAC) are very limited. Methods: To further our knowledge on this topic, we measured relative mtDNA copy...
主要な著者: | Gentiluomo, M, Katzke, V, Kaaks, R, Schmidt, J, Et al. |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
American Association for Cancer Research
2020
|
類似資料
-
Mitochondrial DNA copy number variation, leukocyte telomere length, and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
著者:: Daniele Campa, 等
出版事項: (2018-04-01) -
Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort.
著者:: Hosnijeh, F, 等
出版事項: (2014) -
Mitochondrial DNA copy number variation across human cancers
著者:: Ed Reznik, 等
出版事項: (2016-02-01) -
Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study
著者:: Anika Hüsing, 等
出版事項: (2020-03-01) -
Number of medically prescribed pharmaceutical agents as predictor of mortality risk: a longitudinal, time-variable analysis in the EPIC-Heidelberg cohort
著者:: Verena A. Katzke, 等
出版事項: (2024-01-01)